2.6. Safety Profile
erythema, pain
ADVERSE EVENTS, ADVERSE EFFECTS, ERYTHEMA
No adverse effects, including application-site itching, pain, or post-treatment erythema were observed during the 3-week period of study in the test group. None of the participants dropped out of the study because of adverse events, suggesting that the topical formulation of the test material was safe to use.